ReCode Therapeutics IPO

Develops precision genetic medicines and therapies focused on Cystic Fibrosis, Primary Ciliary Dyskinesia and various cancers and central nervous system diseases.

Register for Details

For more details on financing and valuation for ReCode Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is ReCode Therapeutics's ticker symbol?

ReCode Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is ReCode Therapeutics's stock price?

The stock price for ReCode Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

ReCode Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/10/2023 Series A-3 and B $558.48MM $XXX.XX $XXX.XX
3/26/2020 Series A-1, A-4, and A-5 $160.84MM $XXX.XX $XXX.XX
12/16/2016 Series A-2 $4.63MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about ReCode Therapeutics

What is ReCode Therapeutics funding to date?

ReCode Therapeutics has raised $323.57MM with the following series:
$4.63MM for Series A-2, $160.84MM for Series A-1, A-4, and A-5, $558.48MM for Series A-3 and B

When was ReCode Therapeutics founded?

ReCode Therapeutics was founded in 2015.

Can you invest in ReCode Therapeutics?

ReCode Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell ReCode Therapeutics share pre-IPO?

If you own ReCode Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is ReCode Therapeutics a publicly traded company?

ReCode Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like ReCode Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$4.26B